(Q67726446)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

17 September 2019

main subject

1 reference

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

10 November 2022

author name string

J. M. Vose

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730128

10 November 2022

B. C. Kennedy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730128

10 November 2022

P. J. Bierman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730128

10 November 2022

A. Kessinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730128

10 November 2022

J. O. Armitage

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730128

10 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

10 November 2022

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

10 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

784-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

17 September 2019

cites work

3

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease

10 November 2022

4

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

10 November 2022

5

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

10 November 2022

6

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

10 November 2022

7

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy

10 November 2022

8

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

10 November 2022

9

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous Marrow

10 November 2022

10

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.

10 November 2022

12

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Thyroid and pituitary function following allogeneic bone marrow transplantation

10 November 2022

15

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course

10 November 2022

17

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

10 November 2022

18

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease

10 November 2022

20

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Coronary heart disease after mediastinal irradiation for Hodgkin's disease

10 November 2022

21

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease

10 November 2022

22

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

The Late Appearance of Chronic Pericardial Disease in Patients Treated by Radiotherapy for Hodgkin's Disease

10 November 2022

23

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review

10 November 2022

24

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Late, late doxorubicin cardiotoxicity

10 November 2022

25

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation

10 November 2022

26

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders

10 November 2022

27

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Late effects of total body irradiation

10 November 2022

28

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

A Prospective Study of Infectious Diseases Following Bone Marrow Transplantation: Emergence ofAspergillusandCytomegalovirusas the Major Causes of Mortality

10 November 2022

29

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Infection in bone marrow transplant recipients

10 November 2022

30

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia

10 November 2022

31

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Infection with varicella-zoster virus after marrow transplantation

10 November 2022

32

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients

10 November 2022

33

1 reference

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C784::AID-CNCR2820690328%3E3.0.CO;2-M

10 November 2022

Identifiers

10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730128%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference